Clinical Trial Update: Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis [NA]

View source ↗

Summary

ClinicalTrials.gov entry indicates the Hepaguard trial in adults with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Hepaguard

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Nonalcoholic Fatty Liver Disease | NA | Status: COMPLETED